Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Platelets: linking hemostasis and cancer Jain S; Harris J; Ware JArterioscler Thromb Vasc Biol 2010[Dec]; 30 (12): 2362-7Platelets are the main cellular component in blood responsible for maintaining the integrity of the cardiovascular system via hemostasis. Platelet dysfunction contributes to a wide range of obvious pathological conditions, such as bleeding or thrombosis, but normal platelet function is also linked to diseases not immediately associated with hemostasis or thrombosis, such as cancer. Since the description of Trousseau syndrome in 1865, various experimental and clinical studies have detailed the interaction of platelets with primary tumors and circulating metastatic tumor cells. Observations have suggested that platelets not only augment the growth of primary tumors via angiogenesis but endow tumor cells physical and mechanical support to evade the immune system and extravasate to secondary organs, the basis of metastatic disease. Many laboratory and animal studies have identified specific targets for antiplatelet therapy that may be advantageous as adjuncts to existing cancer treatments. In this review, we summarize important platelet properties that influence tumorigenesis, including primary tumor growth and metastasis at the molecular level. The studies provide a link between the well-studied paradigms of platelet hemostasis and tumorigenesis.|*Hemostasis/drug effects[MESH]|Animals[MESH]|Blood Platelets/drug effects/immunology/*metabolism[MESH]|Cell Proliferation[MESH]|Humans[MESH]|Killer Cells, Natural/immunology[MESH]|Ligands[MESH]|Neoplasm Invasiveness[MESH]|Neoplasms/*blood/blood supply/drug therapy/immunology/pathology[MESH]|Neoplastic Cells, Circulating/drug effects/immunology/*metabolism/pathology[MESH]|Neovascularization, Pathologic/blood[MESH]|Platelet Aggregation Inhibitors/therapeutic use[MESH]|Platelet Membrane Glycoproteins/metabolism[MESH]|Thrombin/metabolism[MESH]|Tumor Burden[MESH]|Tumor Escape[MESH] |